(HYFT - MINDWALK HOLDINGS CORP)

company profile

MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Mindwalk Holdings (HYFT) is trading at 1.305

Open Price
1.32
Previous close
1.305
Previous close
1.305
P/E Ratio
0
Sector
Health Care
Shares outstanding
46987296
Primary exchange
NASDAQ-NMS
ISIN
CA6026871054